Structure Therapeutics In... (GPCR)
NASDAQ: GPCR
· Real-Time Price · USD
21.75
-0.67 (-2.99%)
At close: May 30, 2025, 3:59 PM
21.76
0.05%
After-hours: May 30, 2025, 04:33 PM EDT
-2.99% (1D)
Bid | 21.76 |
Market Cap | 417.14M |
Revenue (ttm) | n/a |
Net Income (ttm) | -143.32M |
EPS (ttm) | -2.58 |
PE Ratio (ttm) | -8.43 |
Forward PE | -14.89 |
Analyst | Buy |
Ask | 23.68 |
Volume | 666,416 |
Avg. Volume (20D) | 952,364 |
Open | 22.44 |
Previous Close | 22.42 |
Day's Range | 21.51 - 22.14 |
52-Week Range | 13.22 - 62.74 |
Beta | -1.79 |
About GPCR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GPCR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GPCR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+1.03%
Structure Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
10 months ago
-1.15%
Shares of weight loss stocks are trading lower, possibly on continued weakness following recent weight loss data from Roche, which could cause competition concerns for companies in the space.

2 months ago · seekingalpha.com
Structure: A Lot Riding On Next Data Readout For Oral GLP-1 CandidateStructure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, al...